CVBT Insider Trading Activity and SEC Form 4 Filings
CVBT insider trading summary
No open-market insider purchases or sales of CardioVascular BioTherapeutics, Inc. (CVBT) have been reported on SEC Form 4 in the past 12 months.
Latest CVBT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 11, 2009 | Thomas Stegmann | 10% Owner | Sell | $59K (218,693 @ $0.27) |
| Aug 11, 2009 | Thomas Stegmann | 10% Owner | Sell | $55K (200,000 @ $0.28) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $48K (200,000 @ $0.24) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $50K (200,000 @ $0.25) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $52K (200,000 @ $0.26) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $56K (200,000 @ $0.28) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $24K (100,000 @ $0.24) |
| Aug 10, 2009 | Thomas Stegmann | 10% Owner | Sell | $54K (200,000 @ $0.27) |
| Aug 7, 2009 | Thomas Stegmann | 10% Owner | Sell | $90K (500,000 @ $0.18) |
| Aug 7, 2009 | Thomas Stegmann | 10% Owner | Sell | $70K (400,000 @ $0.17) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.